Connect with us

Health

AstraZeneca Admits Potential Risk of TTS with Covishield Vaccine: Legal Battle Ensues

Published

7 months ago

on

Times News Global Featured Image

AstraZeneca, the manufacturer of the Covishield vaccine for Covid-19, has made a crucial admission in court documents regarding the vaccine’s potential to induce Thrombosis with Thrombocytopenia Syndrome (TTS), prompting a legal showdown.

Back in 2020 during the Covid-19 crisis, AstraZeneca collaborated with the University of Oxford to develop the AZD1222 vaccine, which in India was produced under the brand Covishield by the Serum Institute of India located in Pune.

TTS is a medical condition characterized by blood clot formation alongside low blood platelet count, presenting rare but severe risks to individuals. The World Health Organization has also flagged TTS as an adverse event following immunization with certain Covid-19 vaccines.

The UK pharmaceutical firm is facing a class action lawsuit over claims that its vaccine resulted in fatalities and severe injuries in some cases, as reported by The Telegraph. The legal battle has escalated with the first case filed by Jamie Scott and his wife Kate over the alleged effects of the AstraZeneca vaccine.

The High Court in the UK has seen a total of 51 cases filed by affected individuals and families seeking compensation, amounting to a staggering UK pound 100 million, as the legal dispute unfolds.

Rachel Adams

Times News Global is a dynamic online news portal dedicated to providing comprehensive and up-to-date news coverage across various domains including politics, business, entertainment, sports, security, features, opinions, environment, education, technology and global. affairs. Our commitment lies in sharing news that is based on factual accuracy, credibility, verifiability, authority and depth of research. We pride ourselves on being a distinctive media organization, guided by the principles enshrined in Article 19 of the Universal Declaration of Human Rights. Made up of a team of ordinary people driven by an unwavering dedication to uncovering the truth, we publish news without bias or intimidation.

Recent Posts